Riadh Daghfous, managing director of the Tunisian National Pharmacovigilance Center (CNPV), describes the role of the CNPV in side-effect monitoring, pharmacovigilance, and marketing authorizations.
CNPV plays a central role in Tunisia’s health system. Could you explain the CNPV’s main operating features, its means and attributions, as well as its interactions with the other bodies of the Tunisian health system?
"We will try to reinforce the collaboration with the European Medical Agency (EMA) as well as with the National Agency for the Safety of Medicines and Health Products (ANSM) in France."
